These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 13130287)

  • 21. Think about drug packaging.
    Prescrire Int; 2012 Dec; 21(133):284. PubMed ID: 23373090
    [No Abstract]   [Full Text] [Related]  

  • 22. Presentation and distribution of medicinal products after the new E.U. marketing procedures.
    Montanari L; Minghetti P; Giudici EM
    Pharmacol Res; 1997 Jan; 35(1):37-42. PubMed ID: 9149314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescribing for the elderly.
    Bliss MR
    Br Med J (Clin Res Ed); 1981 Jul; 283(6285):203-6. PubMed ID: 6789969
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug packaging in 2009: a few advances.
    Prescrire Int; 2010 Jun; 19(107):135-7. PubMed ID: 20738049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of In-Use Photostability: Proposed Guidance for Photostability Testing and Labeling to Support the Administration of Photosensitive Pharmaceutical Products, Part 3. Oral Drug Products.
    Allain L; Baertschi SW; Clapham D; Foti C; Lantaff WM; Reed RA; Templeton AC; Tønnesen HH
    J Pharm Sci; 2016 May; 105(5):1586-1594. PubMed ID: 27056630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Production and control in the pharmaceutical industry. Labeling, packaging and control of endproducts. Organization and practice in medium-size plants].
    Schmid HW
    Pharm Acta Helv; 1973; 48(6):339-57. PubMed ID: 4729556
    [No Abstract]   [Full Text] [Related]  

  • 27. Single dose medication vial packaging deficiencies.
    Craig DB; Martens DJ; Embil JM
    Can J Anaesth; 1998 Jun; 45(6):501-8. PubMed ID: 9669001
    [No Abstract]   [Full Text] [Related]  

  • 28. Conformity of commercial oral single solid unit dose packages in hospital pharmacy practice.
    Thibault M; Prot-Labarthe S; Bussières JF; Lebel D
    Int J Qual Health Care; 2008 Jun; 20(3):206-10. PubMed ID: 18337287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
    Sillo HB; Masota NE; Kisoma S; Rago L; Mgoyela V; Kaale EA
    PLoS One; 2018; 13(5):e0197490. PubMed ID: 29787579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of Stability of Medicines Repackaged in Compliance Aids: A Review.
    Haywood A; Glass BD
    Curr Drug Saf; 2016; 11(1):69-77. PubMed ID: 26412668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Package leaflets of the most consumed medicines in Portugal: safety and regulatory compliance issues. A descriptive study.
    Pires C; Vigário M; Cavaco A
    Sao Paulo Med J; 2015; 133(2):91-100. PubMed ID: 25337666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug packaging in 2014: authorities should direct more efforts towards medication safety.
    Prescrire Int; 2015 May; 24(160):136-8. PubMed ID: 26034808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2011 drug packaging review: too many dangers and too many patients overlooked.
    Prescrire Int; 2012 May; 21(127):133-4, 136-8. PubMed ID: 22827008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How One Might Experimentally Determine if Container Closure Systems and Their Components and Materials of Construction Contribute Elemental Impurities To Packaged Pharmaceutical Drug Products.
    Jenke D
    PDA J Pharm Sci Technol; 2019; 73(2):181-190. PubMed ID: 30232139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Production and control in the pharmaceutical industry. Labeling, packaging and control of endproducts. Demands of directives for endproducts].
    Zinn W
    Pharm Acta Helv; 1973; 48(6):309-21. PubMed ID: 4729554
    [No Abstract]   [Full Text] [Related]  

  • 36. Administering medications in the occupational health setting.
    Bartko M
    Occup Health Saf; 1980 Sep; 49(8):58-60, 62. PubMed ID: 7413130
    [No Abstract]   [Full Text] [Related]  

  • 37. [Production and control in the pharmaceutical industry. Labeling, packaging and control of endproducts. Organization and practice in large plants].
    Hinsen W
    Pharm Acta Helv; 1973; 48(6):322-38. PubMed ID: 4729555
    [No Abstract]   [Full Text] [Related]  

  • 38. [Production and control in the pharmaceutical industry. Labeling, packaging and control of endproducts. Organization and practice in smaller plants].
    Baeschlin K
    Pharm Acta Helv; 1973; 48(6):358-70. PubMed ID: 4729557
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA drug safety communication: FDA requests label changes and single-use packaging for some over-the-counter topical antiseptic products to decrease risk of infection.
    Clin Infect Dis; 2014 Feb; 58(3):i-ii. PubMed ID: 24571007
    [No Abstract]   [Full Text] [Related]  

  • 40. Basics of compounding: repackaging, part 2.
    Allen LV
    Int J Pharm Compd; 2013; 17(2):136-40. PubMed ID: 23696175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.